These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 18220736)
1. Recent developments in studies of l-stepholidine and its analogs: chemistry, pharmacology and clinical implications. Mo J; Guo Y; Yang YS; Shen JS; Jin GZ; Zhen X Curr Med Chem; 2007; 14(28):2996-3002. PubMed ID: 18220736 [TBL] [Abstract][Full Text] [Related]
2. Recent development in studies of tetrahydroprotoberberines: mechanism in antinociception and drug addiction. Chu H; Jin G; Friedman E; Zhen X Cell Mol Neurobiol; 2008 Jun; 28(4):491-9. PubMed ID: 17710533 [TBL] [Abstract][Full Text] [Related]
3. Effects of tetrahydroprotoberberines on dopamine receptor subtypes in brain. Xu SX; Yu LP; Han YR; Chen Y; Jin GZ Zhongguo Yao Li Xue Bao; 1989 Mar; 10(2):104-10. PubMed ID: 2530755 [TBL] [Abstract][Full Text] [Related]
4. The antagonistic effects of tetrahydroprotoberberines on dopamine receptors: electrophysiological studies. Huang KX; Jin GZ Sci China B; 1992 Jun; 35(6):688-96. PubMed ID: 1510818 [TBL] [Abstract][Full Text] [Related]
5. Asymmetric total synthesis and identification of tetrahydroprotoberberine derivatives as new antipsychotic agents possessing a dopamine D(1), D(2) and serotonin 5-HT(1A) multi-action profile. Sun H; Zhu L; Yang H; Qian W; Guo L; Zhou S; Gao B; Li Z; Zhou Y; Jiang H; Chen K; Zhen X; Liu H Bioorg Med Chem; 2013 Feb; 21(4):856-68. PubMed ID: 23332346 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of the antipsychotic effect of bi-acetylated l-stepholidine (l-SPD-A), a novel dopamine and serotonin receptor dual ligand. Guo Y; Zhang H; Chen X; Cai W; Cheng J; Yang Y; Jin G; Zhen X Schizophr Res; 2009 Nov; 115(1):41-9. PubMed ID: 19744833 [TBL] [Abstract][Full Text] [Related]
7. [Clinical study on the treatment of dyskinesia by L-stepholidine]. Le W Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1989 Dec; 22(6):335-7, 381-2. PubMed ID: 2700694 [TBL] [Abstract][Full Text] [Related]
8. [Effects of tetrahydroprotoberberines on dopamine release and 3,4-dihydroxyphenylacetic acid level in corpus striatum measured by in vivo voltammetry]. Huang KX; Sun BC; Gonon FG; Jin GZ Zhongguo Yao Li Xue Bao; 1991 Jan; 12(1):32-6. PubMed ID: 1950581 [TBL] [Abstract][Full Text] [Related]
9. Tetrahydroprotoberberines: A Novel Source of Pharmacotherapies for Substance Use Disorders? Nesbit MO; Phillips AG Trends Pharmacol Sci; 2020 Mar; 41(3):147-161. PubMed ID: 31987662 [TBL] [Abstract][Full Text] [Related]
10. L-Stepholidine, a naturally occurring dopamine D1 receptor agonist and D2 receptor antagonist, attenuates heroin self-administration and cue-induced reinstatement in rats. Yue K; Ma B; Chen L; Tian X; Ru Q; Gan Y; Wang D; Jin G; Li C Neuroreport; 2014 Jan; 25(1):7-11. PubMed ID: 24145772 [TBL] [Abstract][Full Text] [Related]
11. [Progress in studies of the pharmacology of l-tetrahydropalmatine and l-stepholidine]. Jin GZ Yao Xue Xue Bao; 1987 Jun; 22(6):472-80. PubMed ID: 2897152 [No Abstract] [Full Text] [Related]
12. L-stepholidine reduced L-DOPA-induced dyskinesia in 6-OHDA-lesioned rat model of Parkinson's disease. Mo J; Zhang H; Yu LP; Sun PH; Jin GZ; Zhen X Neurobiol Aging; 2010 Jun; 31(6):926-36. PubMed ID: 18707801 [TBL] [Abstract][Full Text] [Related]
13. Effects of (-)stepholidine in animal models for schizophrenia. Ellenbroek BA; Zhang XX; Jin GZ Acta Pharmacol Sin; 2006 Sep; 27(9):1111-8. PubMed ID: 16923330 [TBL] [Abstract][Full Text] [Related]
15. Dopamine D1 receptor agonist and D2 receptor antagonist effects of the natural product (-)-stepholidine: molecular modeling and dynamics simulations. Fu W; Shen J; Luo X; Zhu W; Cheng J; Yu K; Briggs JM; Jin G; Chen K; Jiang H Biophys J; 2007 Sep; 93(5):1431-41. PubMed ID: 17468175 [TBL] [Abstract][Full Text] [Related]
16. l-Stepholidine-induced excitation of dopamine neurons in rat ventral tegmental area is associated with its 5-HT(1A) receptor partial agonistic activity. Gao M; Chu HY; Jin GZ; Zhang ZJ; Wu J; Zhen XC Synapse; 2011 May; 65(5):379-87. PubMed ID: 20803620 [TBL] [Abstract][Full Text] [Related]
17. A preclinical assessment of d.l-govadine as a potential antipsychotic and cognitive enhancer. Lapish CC; Belardetti F; Ashby DM; Ahn S; Butts KA; So K; Macrae CM; Hynd JJ; Miller JJ; Phillips AG Int J Neuropsychopharmacol; 2012 Nov; 15(10):1441-55. PubMed ID: 22071247 [TBL] [Abstract][Full Text] [Related]
18. Molecular insights into the D1R agonist and D2R/D3R antagonist effects of the natural product (-)-stepholidine: molecular modeling and dynamics simulations. Li B; Li W; Du P; Yu KQ; Fu W J Phys Chem B; 2012 Jul; 116(28):8121-30. PubMed ID: 22702398 [TBL] [Abstract][Full Text] [Related]
19. Dual actions of (-)-stepholidine on the dopamine receptor-mediated adenylate cyclase activity in rat corpus striatum. Dong ZJ; Guo X; Chen LJ; Han YF; Jin GZ Life Sci; 1997; 61(4):465-72. PubMed ID: 9244373 [TBL] [Abstract][Full Text] [Related]
20. [Feed-back regulation of presynaptic D2 receptors blockaded by l-stepholidine and l-tetrahydropalmatine]. Chen LJ; Guo X; Wang QM; Jin GZ Zhongguo Yao Li Xue Bao; 1992 Sep; 13(5):442-5. PubMed ID: 1300050 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]